Effect of FRG-8813, a new-type histamine H2-receptor antagonist, on the recurrence of gastric ulcer after healing by drug treatment in rats

Pharmacology

Volumn 61, Issue 2, 2000, Pages 83-90

  Ajioka, Hirofusa ^a   Miyake, Hidekazu ^a   Matsuura, Naosuke ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Endoscopy; FRG 8813; Gastric ulcer recurrence; Histamine H2 antagonist

Indexed keywords

FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LAFUTIDINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENCE RISK; RECURRENT DISEASE; REGENERATION; STOMACH ULCER; TREATMENT OUTCOME;

EID: 0033843382     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028385     Document Type: Article

References (28)

1. Kimura K, Yoshida Y, Kihara K, Kasano T, Ido K: Endoscopic ultrasonographic (EUS) evaluation of the quality of gastric ulcer healing. Gastroenterol Jpn 1993;28:178-185.
2. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR: Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;ii:1437-1442.
3. Arakawa T, Kobayashi K: Quality of ulcer healing: A new concept to rank healed peptic ulcers. Gastroenterol Jpn 1993;28:158-162.
4. Tarnawski A, Stachura J, Krause WI, Douglass TG, Gergely H: Quality of gastric ulcer healing: A new, emerging concept. J Clin Gastroenterol 1991;13:s42-s47.
5. Winship DH: Cimetidine in the treatment of duodenal ulcer. Gastroenterology 1978;74: 402-406.
6. Barr GD, Kang JY, Canalese J, Piper DW: A two-year prospective controlled study of maintenance cimeditine and gastric ulcer. Gastroenterology 1983;85:100-104.
7. 2-receptor antagonists. Aliment Pharmacol Ther 1993;7(suppl 2):27-33.
8. 2 receptor antagonist. Gut 1989;30:449-454.
9. 2 receptor blockade. Gut 1991;32:1455-1460.
10. El-Omar E, Banerjee S, Wirz A, Penman I, Ardill JES, McColl KEL: Marked rebound acid hypersecretion after treatment with ranitidine. Am J Gastroenterol 1996;91:355-359.
11. Arakawa T, Satoh H, Fukuda T, Sakuma H, Nakamura H, Kobayashi K: Gastric mucosal resistance and prostanoid levels after cimetidine treatment in rats. Digestion 1988;41:1-8.
12. Tovey FI, Husband EM, Yiu YC, Baker L, McPhail G, Lewin MR, Jayaraj AP, Clark CG: Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year's maintenance with cimetidine or sulcralfate: A light and electron microscopy study. Gut 1989;30:586-593.
13. Pan S, Liao CH, Lien GS, Chen SH: Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine. Gastroenterology 1991;101:1187-1191.
14. Takemoto T, Kimura K, Okita K, Tsuneoka K, Ohshiba S, Namiki M, Fukuchi S, Miyake T, Fukutomi H, Okazaki Y, Tanaka T: Efficacy of sucralfate in the prevention of recurrence of peptic ulcer: Double blind multicenter study with cimetidine. Scad J Gastroenterol 1987; 22(suppl 140):49-60.
15. 2 receptor antagonist, in rats and dogs. Eur J Pharmacol 1993;235:245-253.
16. 2 receptor antagonist, in rats. Jpn J Pharmacol 1995;68:161-173.
17. Ichikawa T, Ishihara K, Saigenji K, Hotta K: Effects of acid-inhibitory antiulcer drugs on mucin biosynthesis in the rat stomach. Eur J Pharmacol 1994;251:107-111.
18. 2 receptor antagonist, FRG-8813, on gastric mucin in rats with or without acidified ethanol-induced gastric damage. Life Sci 1994; 54:159-164.
19. Tsuji K: Pathogenesis of the gastric ulcer induced by the serosa and mucosa searing method. Jpn J Gastroenterology 1978;75:607-620.
20. Fukawa K, Kawano O, Misaki N, Uchida M, Irino O: Experimental studies on gastric ulcer. 4. Sequential observation and evaluation of gastric ulcers by endoscope in the rat. Jpn J Pharmacol 1983;33:175-179.
21. Okabe S, Pfeiffer CJ: Chronicity of acetic acid ulcer in the rat stomach. Dig Dis 1972;17:619-629.
22. 2 level in rats. Dig Dis Sci 1990;35:80-85.
23. Arakawa T, Watanabe T, Fukuda T, Yamasaki K, Kobayashi K: Rebamipide, novel prostaglandin-inducer, accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer: Comparison with cimetidine. Dig Dis Sci 1995;40:2469-2472.
24. Arakawa T, Watanabe T, Fukuda T, Higuchi K, Takaishi O, Yamasaki K, Kobayashi K, Tarnawski A: Indomethacin treatment during initial period of acetic acid-induced rat gastric ulcer healing promotes persistent polymorphonuclear cell-infiltration and increases future ulcer recurrence: Possible mediation of prostaglandins. Dig Dis Sci 1996;41:2055-2061.
25. Hirose H, Takeuchi K, Okabe S: Effect of indomethacin on gastric mucosal blood flow around acetic acid-induced gastric ulcer. Gastroenterology 1991;100:1259-1265.
26. Konturek SJ, Brzozowski T, Majka J, Pytko-Polonczyk J, Stachura J: Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur J Pharmacol 1993;239:215-217.
27. Pounder R, Smith J: Drug-induced changes of plasma gastrin concentration. Gastroenterol Clin North Am 1990;19:141-153.
28. 2 receptor antagonist. Gut 1988;29:890-893.